Shopping Cart
- Remove All
Your shopping cart is currently empty
PROTAC Mcl1 degrader-1
🥰Excellent
Catalog No. T11975Cas No. 2163793-38-0
PROTAC Mcl1 degrader-1 is a Cereblon ligand-based targeted chimeric protein degrader (PROTAC), a selective Mcl-1 inhibitor. By hijacking the CRBN ubiquitin ligase to form a ternary complex with the target protein, it induces Mcl-1 ubiquitination. It can be used for cancer research.
PROTAC Mcl1 degrader-1
🥰Excellent
Purity: 98.74%
Catalog No. T11975Cas No. 2163793-38-0
PROTAC Mcl1 degrader-1 is a Cereblon ligand-based targeted chimeric protein degrader (PROTAC), a selective Mcl-1 inhibitor. By hijacking the CRBN ubiquitin ligase to form a ternary complex with the target protein, it induces Mcl-1 ubiquitination. It can be used for cancer research.
| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $79 | In Stock | |
| 5 mg | $189 | In Stock | |
| 10 mg | $318 | In Stock | |
| 25 mg | $673 | In Stock | |
| 50 mg | $1,080 | In Stock | |
| 100 mg | $1,730 | In Stock | |
| 200 mg | $2,330 | In Stock |
Add to Cart
Add to Quotation
Bulk & Custom
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
View MoreBatch Information
Select Batch
Purity:98.74%
Contact us for more batch information
Product Introduction
Bioactivity
Chemical Properties
| Description | PROTAC Mcl1 degrader-1 is a Cereblon ligand-based targeted chimeric protein degrader (PROTAC), a selective Mcl-1 inhibitor. By hijacking the CRBN ubiquitin ligase to form a ternary complex with the target protein, it induces Mcl-1 ubiquitination. It can be used for cancer research. |
| Targets&IC50 | MCL1:0.78 μM, Bcl-2:0.54 μM |
| In vitro | PROTAC Mcl1 degrader-1 (Compound C3) induces ubiquitination of Mcl-1 and promotes its proteasomal degradation by binding the Mcl-1 inhibitor S1-6 (with μM range affinity) to the E3 ligase cereblon (CRBN) ligand, pomalidomide.PROTAC Mcl1 degrader-1 selectively targets Mcl-1, a member of the Bcl-2 family, with an IC50 of 078 μM. PROTAC Mcl1 degrader-1 selectively targets Mcl-1 (a member of the Bcl-2 family) with an IC50 of 0.78 μM, and also inhibits Bcl-2 with an IC50 of 0.54 μM. [1] PROTAC Mcl1 degrader-1 (0-10 μM; 0-24 hours) selectively reduces Mcl-1 and Bcl-2 protein levels in HeLa cells by a time- and concentration-dependent mechanism. [1] PROTAC Mcl1 degrader-1 (0-2 μM; 24 hours) exhibits cytotoxic effects on H23 cells. [1] |
| Molecular Weight | 909.84 |
| Formula | C45H45BrN6O8S |
| Cas No. | 2163793-38-0 |
| Smiles | O=C1NC(=O)C(N2C(=O)C=3C=CC=C(NCCCCCCNC(=O)CCCCC(=O)NCCN4C(=O)C5=CC=CC=6C(SC7=CC=C(Br)C=C7)=CC=C(C4=O)C56)C3C2=O)CC1 |
| Relative Density. | no data available |
Storage & Solubility Information
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||
| Solubility Information | DMSO: 40 mg/mL (43.96 mM), Sonication is recommended. | |||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (2.2 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||
Calculator
In Vivo Formulation Calculator (Clear solution)
Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
For example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . A total of 10 animals were administered, and the formula you used is 5% 
DMSO+30% PEG300+5% Tween 80+60% Saline/PBS/ddH2O. So your working solution concentration is 2 mg/mL。Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSO (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
(mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.Preparation method for in vivo formula: Take 50 μL DMSO main solution, add 300 μLPEG300 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLSaline/PBS/ddH2O mix well and clarify
main solution, add 300 μLPEG300 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLSaline/PBS/ddH2O mix well and clarifyFor Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Sci Citations
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Keywords
Preview
Related Tags: buy PROTAC Mcl1 degrader-1 | purchase PROTAC Mcl1 degrader-1 | PROTAC Mcl1 degrader-1 cost | order PROTAC Mcl1 degrader-1 | PROTAC Mcl1 degrader-1 chemical structure | PROTAC Mcl1 degrader-1 in vitro | PROTAC Mcl1 degrader-1 formula | PROTAC Mcl1 degrader-1 molecular weight
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.